December 2004 Archives

Stories like today's about naproxen causing "a 50 percent greater risk of heart attacks and stroke than placebo" can be meaningless if they don't provide the ABSOLUTE risk. The 50% figure is the relative risk -- naproxen's rate relative to placebo. But we're not told the ABSOLUTE rate: how many people actually had heart attacks and strokes in each group. The difference could be very small if the ABSOLUTE numbers are small.

But it's not just journalists who fail to give the absolute risk figures. The New York Times reports that those making the naproxen announcement yesterday would only say that 70 people out of 2,500 in the study experienced heart attacks and strokes. They would not give the numbers for each group. You can do the math to figure it out, but consumers shouldn't have to do the math. Government officials and journalists should help.

Mea Culpa Disclosure: I violated the absolute risk tenet myself in my Dec. 17 entry when I wrote, "Pfizer has stopped a clinical trial for its blockbuster drug Celebrex because it was shown to cause 2.5 times more heart attacks than did placebos."

See my review article in this week's British Medical Journal.

http://bmj.bmjjournals.com/cgi/content/full/329/7478/1352

About this Archive

This page is an archive of entries from December 2004 listed from newest to oldest.

January 2005 is the next archive.

Find recent content on the main index or look in the archives to find all content.